Carregando...

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy

PURPOSE: To determine the efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% preserved with polyquaternium-1 in patients with insufficient response to bimatoprost 0.03%/timolol 0.5% preserved with benzalkonium chloride. PATIENTS AND METHODS: In this open-label nonrandomized stud...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Ophthalmol
Principais autores: Schnober, Dietmar, Hubatsch, Douglas A, Scherzer, Maria-Luise
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4428365/
https://ncbi.nlm.nih.gov/pubmed/26005326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S80880
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!